VCM
NTUS

Virtue Capital Management’s Natus Medical Inc NTUS Stock Holding History

Virtue Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2
Closed – – 662
2017
Q4 		$0 Buy
+2
New +$80 ﹤0.01% 516

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return
VCM
Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

Virtue Capital Management's NTUS Position: Q1 2018 in Review

Virtue Capital Management sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 2 shares.

Virtue Capital Management first reported a position in NTUS in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

  • Virtue Capital Management reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
  • Virtue Capital Management sold 2 Natus Medical Inc shares in Q1 2018.
  • Virtue Capital Management first reported a position in Natus Medical Inc in Q4 2017 and held it in 1 quarter.
  • Virtue Capital Management's Natus Medical Inc position peaked at $0 in Q4 2017.
  • 184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on Virtue Capital Management's 13F filing for Q1 2018, filed 15 May 2018.